Initial Statement of Beneficial Ownership (3)
March 18 2021 - 7:46PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Recknor Chris P |
2. Date of Event Requiring Statement (MM/DD/YYYY)
3/11/2021
|
3. Issuer Name and Ticker or Trading Symbol
CytoDyn Inc. [CYDY]
|
(Last)
(First)
(Middle)
1111 MAIN STREET, SUITE 660 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Chief Operating Officer / |
(Street)
VANCOUVER, WA 98660
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 666666 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Non-qualified Stock Option (right to buy) | 6/10/2020 | 6/10/2025 | Common Stock | 50000 | $6.15 | D | |
Non-qualified Stock Option (right to buy) | (1) | 8/27/2030 | Common Stock | 200000 | $3.15 | D | |
Explanation of Responses: |
(1) | Non-qualified stock option vests in three equal annual installments beginning on August 27, 2021. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Recknor Chris P 1111 MAIN STREET SUITE 660 VANCOUVER, WA 98660 |
|
| Chief Operating Officer |
|
Signatures
|
Arian Colachis, Attorney-in-fact | | 3/18/2020 |
**Signature of Reporting Person | Date |
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Aug 2024 to Sep 2024
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Sep 2023 to Sep 2024